In a clinical trial, patients with RA who consumed Lactobacillus casei for 8 weeks showed a significant decrease in disease activity score, along with reduced serum levels of proinflammatory cytokines such as tumor necrosis factor-α, IL-6, and IL-12 (117). This evidence concerns the gene IL6 and rheumatoid arthritis.